Hainan Haiyao announced that Haikou Pharmaceutical Co., Ltd., a wholly-owned subsidiary, recently obtained the “Drug Registration Certificate” for injectable esaconazole sulfate approved and issued by the State Drug Administration. The specification is 200mg, which is suitable for treating aggressive aspergillosis and invasive trichomoniasis in adults and children aged 1 year and above.

Zhitongcaijing · 2d ago
Hainan Haiyao announced that Haikou Pharmaceutical Co., Ltd., a wholly-owned subsidiary, recently obtained the “Drug Registration Certificate” for injectable esaconazole sulfate approved and issued by the State Drug Administration. The specification is 200mg, which is suitable for treating aggressive aspergillosis and invasive trichomoniasis in adults and children aged 1 year and above.